PENSION & WEALTH MANAGEMENT ADVISORS, INC.’s Royalty Pharma RPRX Stock Holding History

PENSION & WEALTH MANAGEMENT ADVISORS, INC.’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$47.8K	Buy	+852	New	+$44.3K	0.01%	325

Other funds holding RPRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Mitsubishi UFJ Trust & Banking Tokyo, Japan $45.7B AUM 34.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

PENSION & WEALTH MANAGEMENT ADVISORS, INC.'s RPRX Position: Q2 2026 in Review

PENSION & WEALTH MANAGEMENT ADVISORS, INC. opened a new position in Royalty Pharma (RPRX) in Q2 2026: 852 shares worth $47.8K. The stake represents 0.01% of the portfolio and ranks #325 among its holdings.

296 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

PENSION & WEALTH MANAGEMENT ADVISORS, INC. held 852 shares of Royalty Pharma worth $47.8K as of Q2 2026.
Royalty Pharma was a new PENSION & WEALTH MANAGEMENT ADVISORS, INC. position in Q2 2026.
Royalty Pharma made up 0.01% of PENSION & WEALTH MANAGEMENT ADVISORS, INC.'s portfolio in Q2 2026, its #325 holding.
296 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on PENSION & WEALTH MANAGEMENT ADVISORS, INC.'s 13F filing for Q2 2026, filed 7 Aug 2026.